AKTS
Aktis Oncology, Inc.
18.50$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -16.0% | +0.2% | +7.0% | +20.2% | -89.7% | +55.1% | +10.6% | -1.4% | +18.4% | +72.6% | +4.9% | – | |
| – | -19.4% | -21.6% | +13.0% | -34.0% | – | – | – | – | – | – | +34.8% | – | |
| – | – | – | -48.8% | +1,132.7% | -78.3% | – | – | – | +18.4% | +37.7% | -2.7% | – | |
| – | +26.7% | -38.0% | -6.9% | -54.9% | +367.9% | +25.8% | +17.4% | -11.6% | +0.2% | +21.5% | +26.2% | – | |
| – | +26.9% | -9.1% | -3.9% | -22.3% | -43.2% | -15.1% | +10.0% | -16.8% | -18.0% | +112.8% | +19.9% | – | |
| – | +26.8% | -23.7% | +0.6% | -39.0% | +71.9% | +18.2% | +15.2% | -12.3% | -2.7% | +31.4% | +24.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +32.2% | +40.0% | +9.7% | -4.3% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +100.0% | +0.0% | -50.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.